Filtering by:
Prostate CancerFDA Approves Consumer Test for Certain BRCA Mutations
The US Food and Drug Administration (FDA) has approved the first direct-to-consumer tests for certain BRCA1 and BRCA2 gene mutations.
FDA Approves Erleada (Apalutamide) for Some Prostate Cancers
The US Food and Drug Administration (FDA) has approved Erleada (apalutamide) to treat men with non-metastatic castration-resistant prostate cancer.
Facts & Figures 2018: Rate of Deaths From Cancer Continues Decline
The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society.
Study: Observation as Good as Surgery in Early-stage Prostate Cancer
A major 20-year study led by the Minneapolis Veterans Affairs Health Care System has found more evidence that surgery for early-stage prostate cancer does not help men live longer than observation.
Prostate Cancer Screening FAQ
The American Cancer Society, along with other leading medical organizations, recommends informed decision-making when it comes to screening for prostate cancer.
Annual Report to the Nation: Cancer Death Rates Continue to Drop
The death rate from cancer in the United States is continuing to decline among men, women, and children, according to the latest Annual Report to the Nation on the Status of Cancer.
Prostate and Rectal Cancer Survivor Turns to Faith
When Alan Clingan was diagnosed with rectal cancer in 2016, he began searching for meaning. A pastor, he naturally turned to religion. “You wonder why you get cancer,” said Clingan. “How is the Lord using me in this situation?"
Cancer Death Rates Vary Greatly Among US Counties
Researchers in Seattle analyzed the death rate from 29 cancer types in every county in the United States between 1980 and 2014.